Indivior seeks FDA approval for drug to treat opioid abuse

May 30 (Reuters) - British drugmaker Indivior Plc stated on Tuesday it applied for a brand new drug application to the U.S. Food and Drug Administration to marketplace its drug to treat opioid use ailment (OUD).

The drug, RBP-6000, is a monthly injectable opioid, used to treat OUD as part of a remedy plan that includes counselling and mental guide, Indivior stated.

OUD is characterized by way of a compulsive use of opioid materials, whilst they may be taken in immoderate quantities, often serving no scientific motive.

About four.Three million Americans engaged in non-medicinal use of painkillers inclusive of opioids, even as 1.9 million met the criteria for painkiller use disorder, Indivior stated.

Opioid abuse, overdose and dependancy have assumed epidemic proportions within the United States, partly because of unrestricted prescription of narcotic painkillers in addition to the paucity of get entry to to substance-abuse remedy packages. (Reporting by way of Sanjeeban Sarkar in Bengaluru; Editing with the aid of Sai Sachin Ravikumar)

https://highclasslondonescorts.agency